Who Owns ZYBT?
Zhengye Biotechnology Holding Limited — Institutional Ownership & 13F Holdings
$0.96
-0.13 (-12.02%)
Market Cap
$35.5M
Shares Outstanding
—
Institutional Holders
3
Total Inst. Value
$7K
% of Float Held
—
QoQ Holder Change
—
Institutional data as of Q1 2025
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | UBS Group AG | $7K | 1,289 |
| 2 | Tower Research Capital LLC (TRC) | $5 | 1 |
| 3 | MORGAN STANLEY | $0 | 46 |
Related Stocks
Frequently Asked Questions
How many institutional investors hold ZYBT?
As of Q1 2025, 3 institutional investors report holding ZYBT (Zhengye Biotechnology Holding Limited) in their 13F filings.
Which hedge fund owns the most ZYBT?
The largest institutional holder of ZYBT is UBS Group AG with $7K in shares.
Are institutions buying or selling ZYBT?
This quarter, 3 institutions opened new positions in ZYBT and 0 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.